(Q45853347)

16 December 2017

title

Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trial (English)

1 reference

16 December 2017

0 references

1 reference

Matthias Griese

1

1 reference

16 December 2017

Matthias Kappler

2

1 reference

16 December 2017

Claudia Eismann

3

1 reference

16 December 2017

Manfred Ballmann

4

1 reference

16 December 2017

Sibylle Junge

5

1 reference

16 December 2017

Ernst Rietschel

6

1 reference

16 December 2017

Silke van Koningsbruggen-Rietschel

7

1 reference

16 December 2017

Doris Staab

8

1 reference

16 December 2017

Claudia Rolinck-Werninghaus

9

1 reference

16 December 2017

Uwe Mellies

10

1 reference

16 December 2017

Thomas Köhnlein

11

1 reference

16 December 2017

Thomas Wagner

12

1 reference

16 December 2017

Susanne König

13

1 reference

16 December 2017

Helmut Teschler

14

1 reference

16 December 2017

Hans-Eberhard Heuer

15

1 reference

16 December 2017

Matthias Kopp

16

1 reference

16 December 2017

Susanne Heyder

17

1 reference

16 December 2017

Jutta Hammermann

18

1 reference

16 December 2017

Peter Küster

19

1 reference

16 December 2017

Marguerite Honer

20

1 reference

16 December 2017

Ulrich Mansmann

21

1 reference

16 December 2017

Ingrid Beck-Speier

22

1 reference

16 December 2017

Dominik Hartl

23

1 reference

16 December 2017

Carola Fuchs

24

1 reference

16 December 2017

Glutathione Study Group

25

1 reference

16 December 2017

Andreas Hector

26

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 July 2013

1 reference

16 December 2017

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

16 December 2017

volume

188

1 reference

16 December 2017

issue

1

1 reference

16 December 2017

page(s)

83-89

1 reference

16 December 2017

Infection, inflammation, and lung function decline in infants with cystic fibrosis.

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0427OC

Innate immunity in cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0427OC

Oxidative stress and antioxidant therapy in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0427OC

Antioxidants in cystic fibrosis. Conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11-12, 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0427OC

Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0427OC

Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0427OC

Pulmonary oxidative stress response in young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0427OC

Hypertonic saline increases lung epithelial lining fluid glutathione and thiocyanate: two protective CFTR-dependent thiols against oxidative injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0427OC

Glutathione and glutathione peroxidase in sputum samples of adult patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0427OC

A pilot study of the effect of inhaled buffered reduced glutathione on the clinical status of patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0427OC

Improvement in clinical markers in CF patients using a reduced glutathione regimen: an uncontrolled, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0427OC

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0427OC

The revised German Cystic Fibrosis Questionnaire: validation of a disease-specific health-related quality of life instrument

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0427OC

Novel method to process cystic fibrosis sputum for determination of oxidative state

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0427OC

Denufosol tetrasodium in patients with cystic fibrosis and normal to mildly impaired lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0427OC

A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0427OC

Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0427OC

Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0427OC

Contribution by polymorphonucleate granulocytes to elevated gamma-glutamyltransferase in cystic fibrosis sputum

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0427OC

New insights into the pathogenesis of cystic fibrosis: pivotal role of glutathione system dysfunction and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0427OC

10.1164/RCCM.201303-0427OC

21 January 2018

Identifiers

DOI

1 reference

16 December 2017

1 reference

16 December 2017